Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Metastasis
ADR ID BADD_A06072
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.01      Metastases to unknown and unspecified sites
16.22.01.001      Metastasis
Description The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. [MeSH]
MedDRA Code 10062194
MeSH ID D009362
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Metastases NOS | Secondary carcinoma | Secondary carcinoma (known primary) | Secondary malignant neoplasm of other specified site | Secondary malignant neoplasm of other specified site, not elsewhere classified | Secondary malignant neoplasm of other specified sites | Secondary malignant neoplasm of respiratory and digestive systems | Metastasis | Neoplasm Metastasis | Metastases, Neoplasm | Neoplasm Metastases | Metastases | Metastasis, Neoplasm
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01257Letrozole0.001926%
BADD_D01281Levonorgestrel--
BADD_D01378Memantine0.000226%
BADD_D01418Methotrexate--
BADD_D01480Mitoxantrone--
BADD_D01567Nilotinib0.000208%
BADD_D01601Olaparib0.000486%
BADD_D01629Osimertinib0.000625%
BADD_D01633Oxaliplatin0.000347%
BADD_D01654Palbociclib0.000417%
BADD_D01661Pamidronate disodium--
BADD_D01662Pamidronic acid--
BADD_D01687Pazopanib0.000834%
BADD_D01835Pregabalin--
BADD_D01922Regorafenib0.000486%
BADD_D01954Rivaroxaban--
BADD_D02026Simvastatin0.000020%
BADD_D02028Sirolimus0.000179%
BADD_D02029Sitagliptin0.000130%
BADD_D02058Sorafenib0.000625%
BADD_D02100Sunitinib--
BADD_D02105Tacrolimus0.000370%
BADD_D02150Temozolomide0.000208%
BADD_D02297Triptorelin--
BADD_D02344Vemurafenib0.000734%
BADD_D02345Venetoclax0.000139%
BADD_D02365Vismodegib0.000139%
BADD_D02392Zoledronic acid0.011981%
BADD_D02406Radium ra 223 dichloride-
BADD_D02412Octreotide0.004602%
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages